Beliefs and behavioural intentions towards pharmacotherapy for stuttering

a survey of adults who stutter

Research output: Contribution to journalArticle

Abstract

Purpose
Although considerable efforts have been made to investigate the effectiveness of pharmacological treatments for stuttering, little is known about how the stuttering community perceives these treatments. This study aimed to assess and quantify beliefs regarding pharmacotherapy for adults who stutter and to establish whether behavioural intentions to undertake treatment were related to these beliefs.

Method
An adapted version of the Beliefs about Medicine Questionnaire was completed by adults who stutter. Participants also reported perceptions of their stuttering including its overall impact, ratings of previous speech therapy, and behavioural intentions to initiate pharmacotherapy and speech therapy in future.

Results
Necessity and concern beliefs were distributed widely across the sample and in a pattern indicating a relatively balanced perception of the benefits and costs of medication prescribed specifically for stuttering. Of the study’s measures, the necessity-concerns differential most strongly predicted the behavioural intention to initiate pharmacotherapy. The overall impact of stuttering predicted intentions to seek both pharmacotherapy and speech therapy. Participants reported the likelihood of pursuing pharmacotherapy and speech therapy in equal measure.

Conclusions
The theoretical model of medication representations appears to be a useful framework for understanding the beliefs of adults who stutter towards the medical treatment of their disorder. The findings of this study may be of interest to clinicians and researchers working in the field of stuttering treatment and to people who stutter considering pharmacotherapy.
Original languageEnglish
Pages (from-to)15-24
Number of pages10
JournalJournal of Communication Disorders
Volume73
Early online date13 Mar 2018
DOIs
Publication statusPublished - 31 May 2018

Fingerprint

speech therapy
Stuttering
Speech Therapy
Drug Therapy
medication
physician's care
rating
medicine
Therapeutics
Cost-Benefit Analysis
Surveys and Questionnaires
questionnaire
Theoretical Models
costs
Research Personnel
Medicine
Pharmacology
community

Keywords

  • stuttering
  • stammering
  • pharmacotherapy
  • medication
  • speech therapy
  • treatment

Cite this

@article{a9bba33fa28c46fbb1d6516dea9ae0cf,
title = "Beliefs and behavioural intentions towards pharmacotherapy for stuttering: a survey of adults who stutter",
abstract = "PurposeAlthough considerable efforts have been made to investigate the effectiveness of pharmacological treatments for stuttering, little is known about how the stuttering community perceives these treatments. This study aimed to assess and quantify beliefs regarding pharmacotherapy for adults who stutter and to establish whether behavioural intentions to undertake treatment were related to these beliefs.MethodAn adapted version of the Beliefs about Medicine Questionnaire was completed by adults who stutter. Participants also reported perceptions of their stuttering including its overall impact, ratings of previous speech therapy, and behavioural intentions to initiate pharmacotherapy and speech therapy in future.ResultsNecessity and concern beliefs were distributed widely across the sample and in a pattern indicating a relatively balanced perception of the benefits and costs of medication prescribed specifically for stuttering. Of the study’s measures, the necessity-concerns differential most strongly predicted the behavioural intention to initiate pharmacotherapy. The overall impact of stuttering predicted intentions to seek both pharmacotherapy and speech therapy. Participants reported the likelihood of pursuing pharmacotherapy and speech therapy in equal measure.ConclusionsThe theoretical model of medication representations appears to be a useful framework for understanding the beliefs of adults who stutter towards the medical treatment of their disorder. The findings of this study may be of interest to clinicians and researchers working in the field of stuttering treatment and to people who stutter considering pharmacotherapy.",
keywords = "stuttering, stammering, pharmacotherapy, medication, speech therapy, treatment",
author = "Allan McGroarty and Rebecca McCartan",
year = "2018",
month = "5",
day = "31",
doi = "10.1016/j.jcomdis.2018.03.002",
language = "English",
volume = "73",
pages = "15--24",
journal = "Journal of Communication Disorders",
issn = "0021-9924",

}

TY - JOUR

T1 - Beliefs and behavioural intentions towards pharmacotherapy for stuttering

T2 - a survey of adults who stutter

AU - McGroarty, Allan

AU - McCartan, Rebecca

PY - 2018/5/31

Y1 - 2018/5/31

N2 - PurposeAlthough considerable efforts have been made to investigate the effectiveness of pharmacological treatments for stuttering, little is known about how the stuttering community perceives these treatments. This study aimed to assess and quantify beliefs regarding pharmacotherapy for adults who stutter and to establish whether behavioural intentions to undertake treatment were related to these beliefs.MethodAn adapted version of the Beliefs about Medicine Questionnaire was completed by adults who stutter. Participants also reported perceptions of their stuttering including its overall impact, ratings of previous speech therapy, and behavioural intentions to initiate pharmacotherapy and speech therapy in future.ResultsNecessity and concern beliefs were distributed widely across the sample and in a pattern indicating a relatively balanced perception of the benefits and costs of medication prescribed specifically for stuttering. Of the study’s measures, the necessity-concerns differential most strongly predicted the behavioural intention to initiate pharmacotherapy. The overall impact of stuttering predicted intentions to seek both pharmacotherapy and speech therapy. Participants reported the likelihood of pursuing pharmacotherapy and speech therapy in equal measure.ConclusionsThe theoretical model of medication representations appears to be a useful framework for understanding the beliefs of adults who stutter towards the medical treatment of their disorder. The findings of this study may be of interest to clinicians and researchers working in the field of stuttering treatment and to people who stutter considering pharmacotherapy.

AB - PurposeAlthough considerable efforts have been made to investigate the effectiveness of pharmacological treatments for stuttering, little is known about how the stuttering community perceives these treatments. This study aimed to assess and quantify beliefs regarding pharmacotherapy for adults who stutter and to establish whether behavioural intentions to undertake treatment were related to these beliefs.MethodAn adapted version of the Beliefs about Medicine Questionnaire was completed by adults who stutter. Participants also reported perceptions of their stuttering including its overall impact, ratings of previous speech therapy, and behavioural intentions to initiate pharmacotherapy and speech therapy in future.ResultsNecessity and concern beliefs were distributed widely across the sample and in a pattern indicating a relatively balanced perception of the benefits and costs of medication prescribed specifically for stuttering. Of the study’s measures, the necessity-concerns differential most strongly predicted the behavioural intention to initiate pharmacotherapy. The overall impact of stuttering predicted intentions to seek both pharmacotherapy and speech therapy. Participants reported the likelihood of pursuing pharmacotherapy and speech therapy in equal measure.ConclusionsThe theoretical model of medication representations appears to be a useful framework for understanding the beliefs of adults who stutter towards the medical treatment of their disorder. The findings of this study may be of interest to clinicians and researchers working in the field of stuttering treatment and to people who stutter considering pharmacotherapy.

KW - stuttering

KW - stammering

KW - pharmacotherapy

KW - medication

KW - speech therapy

KW - treatment

UR - https://www.sciencedirect.com/science/article/pii/S0021992417302149

U2 - 10.1016/j.jcomdis.2018.03.002

DO - 10.1016/j.jcomdis.2018.03.002

M3 - Article

VL - 73

SP - 15

EP - 24

JO - Journal of Communication Disorders

JF - Journal of Communication Disorders

SN - 0021-9924

ER -